BETAXOLOL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Betaxolol Hydrochloride patents expire, and what generic alternatives are available?
Betaxolol Hydrochloride is a drug marketed by Acella, Apotex Inc, Medimetriks Pharms, Sciegen Pharms Inc, Epic Pharma, and Kvk Tech. and is included in six NDAs.
The generic ingredient in BETAXOLOL HYDROCHLORIDE is betaxolol hydrochloride. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the betaxolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Betaxolol Hydrochloride
A generic version of BETAXOLOL HYDROCHLORIDE was approved as betaxolol hydrochloride by EPIC PHARMA on October 22nd, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BETAXOLOL HYDROCHLORIDE?
- What are the global sales for BETAXOLOL HYDROCHLORIDE?
- What is Average Wholesale Price for BETAXOLOL HYDROCHLORIDE?
Summary for BETAXOLOL HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 123 |
| Clinical Trials: | 5 |
| Patent Applications: | 1,685 |
| What excipients (inactive ingredients) are in BETAXOLOL HYDROCHLORIDE? | BETAXOLOL HYDROCHLORIDE excipients list |
| DailyMed Link: | BETAXOLOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BETAXOLOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Zagazig University | Phase 2 |
| The New York Community Trust | Phase 4 |
| Weill Medical College of Cornell University | Phase 4 |
Pharmacology for BETAXOLOL HYDROCHLORIDE
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for BETAXOLOL HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for BETAXOLOL HYDROCHLORIDE
US Patents and Regulatory Information for BETAXOLOL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acella | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 078694-001 | Nov 16, 2009 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Kvk Tech | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | TABLET;ORAL | 078962-001 | Jun 27, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sciegen Pharms Inc | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075386-001 | Jun 30, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Kvk Tech | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | TABLET;ORAL | 078962-002 | Jun 27, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Apotex Inc | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075446-001 | Sep 28, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Medimetriks Pharms | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075630-001 | Apr 12, 2001 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Epic Pharma | BETAXOLOL HYDROCHLORIDE | betaxolol hydrochloride | TABLET;ORAL | 075541-002 | Oct 22, 1999 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
